NM_025099.6:c.2831dupC
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_025099.6(CTC1):c.2831dupC(p.His945SerfsTer56) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000805 in 1,614,008 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_025099.6 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152136Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000120 AC: 3AN: 249486Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135350
GnomAD4 exome AF: 0.00000752 AC: 11AN: 1461872Hom.: 0 Cov.: 32 AF XY: 0.00000688 AC XY: 5AN XY: 727240
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152136Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74310
ClinVar
Submissions by phenotype
Cerebroretinal microangiopathy with calcifications and cysts 1 Pathogenic:1
Variant summary: CTC1 c.2831dupC (p.His945SerfsX56) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant allele was found at a frequency of 1.2e-05 in 249486 control chromosomes (gnomAD). c.2831dupC has been reported in the compound heterozygous state in the literature in an individual affected with Coats plus (Anderson_2012). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 and both classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as likely pathogenic. -
not provided Pathogenic:1
DNA sequence analysis of the CTC1 gene demonstrated a single base pair duplication in exon 17, c.2831dup. This pathogenic sequence change results in an amino acid frameshift and creates a premature stop codon 55 amino acids downstream of the change, p.His945Serfs*56. This sequence change is predicted to result in an abnormal transcript, which may be degraded, or may lead to the production of a truncated CTC1 protein with potentially abnormal function. This sequence change has previously been described in a patient with Coats Plus disease in a compound heterozygous state with another splice site variant (PMID: 22267198). This sequence change has been described in the gnomAD database with a low population frequency of 0.0014% (dbSNP rs779650334); it has been observed in 4 heterozygous individuals. -
Dyskeratosis congenita Pathogenic:1
This sequence change creates a premature translational stop signal (p.His945Serfs*56) in the CTC1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CTC1 are known to be pathogenic (PMID: 22267198, 22387016). This variant is present in population databases (rs779650334, gnomAD 0.003%). This premature translational stop signal has been observed in individual(s) with Coats plus syndrome (PMID: 22267198). ClinVar contains an entry for this variant (Variation ID: 840769). For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at